Opioid Withdrawal Treatment market Rising Trends, Demand and Future Scope 2025 to 2034 ...

View upcoming earnings forecasts and in-depth analysis of company forecasts.

Dr. Vink brings over 35 years of industry experience and currently serves as Chairman and Board member of several public and ...

Support OpenSecrets during our NewsMatch campaign and double your donation! Help keep our resources and data free for the general public.

Additionally, the ongoing appeal with Mylan regarding patent infringement ... Regeneron Pharmaceuticals, Inc. is a New York-based biotechnology company, which discovers, develops, manufactures ...

Support OpenSecrets during our NewsMatch campaign and double your donation! Help keep our resources and data free for the general public.

The ʼ865 patent has been the subject of other patent infringement lawsuits against Mylan and Biocon Biologics Inc. (“Biocon”); Samsung Bioepis Co., Ltd. (“Samsung”); Celltrion ...

The Nasal Drug Delivery Technology Market is driven by the rising demand for non-invasive administration methods that enhance patient compliance and bioavailability. Innovations such as advanced ...

DUBLIN, Nov. 12, 2024 /PRNewswire/ -- Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today reported financial and operational results for the third quarter of 2024 ...

Viatris Inc. stock has experienced significant volatility ... inherited from Pfizer / Mylan. The company earned ~$1.3bn in Europe in Q2, ~$1bn in the US, ~$580m in emerging markets, $350m in ...

Researchers are exploring how small airway abnormalities in younger smokers could help identify who is at risk of developing COPD and establish how the chronic lung disease progresses.